HUMAN METABOLITE OF NALTREXONE (N-CYCLOPROPYLMETHYLNOROXYMORPHONE) WITH A NOVEL C-6 ISOMORPHINE CONFIGURATIONCONE EJ.1973; TETRAHEDRON LETTERS; G.B.; DA. 1973; NO 28; PP. 2607-2610; BIBL. 14REF.Serial Issue

AN EVALUATION OF THE HOT PLATE TECHNIQUE TO STUDY NARCOTIC ANTAGONISTSHEILMAN RD; GRAY MI; CHEN RP et al.1976; RES. COMMUNIC. CHEM. PATHOL. PHARMACOL.; U.S.A.; DA. 1976; VOL. 13; NO 4; PP. 635-647; BIBL. 12 REF.Article

STUDIES OF EN-1639A (NALTREXONE): A NEW NARCOTIC ANTAGONISTRESNICK RB; VOLAVKA J; FREEDMAN AM et al.1974; AMER. J. PSYCHIATRY; U.S.A.; DA. 1974; VOL. 131; NO 6; PP. 646-650; BIBL. 6REF.Article

A 6-month controlled naltrexone study: Combined effect with cognitive behavioral therapy in outpatient treatment of alcohol dependenceBALLDIN, J; BERGLUND, M; WILLANDER, A et al.Alcoholism, clinical and experimental research. 2003, Vol 27, Num 7, pp 1142-1149, issn 0145-6008, 8 p.Article

TRITIATED NALTREXONE BINDING IN PLASMA FROM SEVERAL SPECIES AND TISSUE DISTRIBUTION IN MICE = LA FIXATION DE NALTREXONE TRITIEE DANS LE PLASMA DE PLUSIEURS ESPECES ET LA REPARTITION TISSULAIRE CHEZ LES SOURISLUDDEN TM; MALSPEIS L; BAGGOT JD et al.1976; J. PHARM. SCI.; U.S.A.; DA. 1976; VOL. 65; NO 5; PP. 712-716; BIBL. 25 REF.Article

AVERSIVE EFFECTS OF NALTREXONE IN SUBJECTS NOT DEPENDENT ON OPIATESHOLLISTER LE; JOHNSON K; BOUKHABZA D et al.1981; DRUG AND ALCOHOL DEPEND.; ISSN 0376-8716; CHE; DA. 1981; VOL. 8; NO 1; PP. 37-41; BIBL. 4 REF.Article

Pain as a reward: Changing the meaning of pain from negative to positive co-activates opioid and cannabinoid systemsBENEDETTI, Fabrizio; THOEN, Wilma; BLANCHARD, Catherine et al.Pain (Amsterdam). 2013, Vol 154, Num 3, pp 361-367, issn 0304-3959, 7 p.Article

Effects of naltrexone on alcohol drinking patterns and extinction of alcohol seeking in baboonsKAMINSKI, Barbara J; DUKE, Angela N; WEERTS, Elise M et al.Psychopharmacologia. 2012, Vol 223, Num 1, pp 55-66, issn 0033-3158, 12 p.Article

Adverse events in the removal of naltrexone implantsSADLEIR, P. H. M; GARDNER, A. I; HENNESSY, B et al.Anaesthesia and intensive care. 2011, Vol 39, Num 5, pp 895-898, issn 0310-057X, 4 p.Article

Pharmacokinetics and dialysability of naltrexone in patients undergoing hemodialysisKAMBIA, Nicolas K; DINE, Thierry; ODOU, Pascal et al.European journal of drug metabolism and pharmacokinetics. 2004, Vol 29, Num 4, pp 225-230, issn 0378-7966, 6 p.Article

NARCOTIC ANTAGONIST TREATMENT: CLINICAL EXPERIENCE WITH NALTREXONELEWIS DC; MAYER J; HERSCH RG et al.1978; INTERNATION. J. ADDICT.; USA; DA. 1978; VOL. 13; NO 6; PP. 961-973; BIBL. 9 REF.Article

How cognitive assessment through clinical neurophysiology may help optimize chronic alcoholism treatmentCAMPANELLA, S; PETIT, G; VERBANCK, P et al.Neurophysiologie clinique (Paris). 2011, Vol 41, Num 3, pp 115-123, issn 0987-7053, 9 p.Article

THE TREATMENT OF HEROIN ADDICTION: NALTREXONE ALONE AND WITH BEHAVIOR THERAPYCALLAHAN EJ; RAWSON RA; MCCLEAVE B et al.1980; INT. J. ADDICT.; ISSN 0020-773X; USA; DA. 1980; VOL. 15; NO 6; PP. 795-807; BIBL. 2 P.Article

NALTREXONE TREATMENT OF OPIATE-DEPENDENT PERSONS.HOLLISTER LE; SCHWIN RL; KABPER P et al.1977; DRUG ALCOHOL DEPEND.; SWITZ.; DA. 1977; VOL. 2; NO 3; PP. 203-209; BIBL. 11 REF.Article

Naltrexone for the management of post-burn pruritus : A preliminary reportLASALLE, L; RACHELSKA, G; NEDELEC, B et al.Burns. 2008, Vol 34, Num 6, pp 797-802, issn 0305-4179, 6 p.Article

Naltrexone's suppressant effects on drinking are limited to the first 3 months of treatmentDAVIDSON, Dena; WIRTZ, Philip W; GULLIVER, Suzy Bird et al.Psychopharmacologia. 2007, Vol 194, Num 1, pp 1-10, issn 0033-3158, 10 p.Article

Single- and multiple-dose pharmacokinetics of long-acting injectable naltrexoneDUNBAR, Joi L; TURNCLIFF, Ryan Z; QUNMING DONG et al.Alcoholism, clinical and experimental research. 2006, Vol 30, Num 3, pp 480-490, issn 0145-6008, 11 p.Article

Naltrexone attenuates acute cigarette smoking behaviorEPSTEIN, Alyssa M; KING, Andrea C.Pharmacology, biochemistry and behavior. 2004, Vol 77, Num 1, pp 29-37, issn 0091-3057, 9 p.Article

Naltrexone effects on alcohol consumption in a clinical laboratory paradigm: temporal effects of drinkingANTON, Raymond F; DROBES, David J; VORONIN, Konstantin et al.Psychopharmacologia. 2004, Vol 173, Num 1-2, pp 32-40, issn 0033-3158, 9 p.Article

Effect of Extended-Release Naltrexone (XR-NTX) on Quality of Life in Alcohol-Dependent PatientsPETTINATI, Helen M; GASTFRIEND, David R; QUNMING DONG et al.Alcoholism, clinical and experimental research. 2009, Vol 33, Num 2, pp 350-356, issn 0145-6008, 7 p.Article

A GAS-LIQUID CHROMATOGRAPHIE METHOD FOR THE DETERMINATION OF NALTREXONE AND BETA-NALTREXOL IN HUMAN URINE = UNE METHODE DE CHROMATOGRAPHIE GAZ-LIQUIDE POUR LE DOSAGE DE LA NALTREXONE ET DU BETA -NALTREXOL DANS L'URINE HUMAINEVEREBELY K; MULE SJ; JUKOFSKY D et al.1975; J. CHROMATOGR.; NETHERL.; DA. 1975; VOL. 111; NO 1; PP. 141-148; BIBL. 9 REF.Article

ISOLATION AND STEREOCHEMICAL IDENTIFICATION OF A METABOLITE OF NALTREXONE FROM HUMAN URINE = ISOLEMENT ET IDENTIFICATION STEREOCHIMIQUE D'UN METABOLITE DE LA NALTREXONE A PARTIR DE L'URINE HUMAINENITHIANANDA CHATTERJIE; FUJIMOTO JM; INTURRISI CE et al.1974; DRUG METABOL. DISPOSIT.; U.S.A.; DA. 1974; VOL. 2; NO 5; PP. 401-405; BIBL. 12 REF.Article

THE URINARY EXCRETION PROFILE OF NALTREXONE AND METABOLITES IN MAN = LE PROFIL DE L'EXCRETION URINAIRE DE LA NALTREXONE ET DE SES METABOLITES CHEZ L'HOMMECONE EJ; GORODETZKY CW; YEH SY et al.1974; DRUG METABOL. DISPOSIT.; U.S.A.; DA. 1974; VOL. 2; NO 6; PP. 506-512; BIBL. 14REF.Article

Risk Factors for Craving and Relapse in Heroin Users Treated with Oral or Implant NaltrexoneHULSE, Gary K; NGO, Hanh T. T; TAIT, Robert J et al.Biological psychiatry (1969). 2010, Vol 68, Num 3, pp 296-302, issn 0006-3223, 7 p.Article

New therapeutic options for alcohol dependence : Long-acting intramuscular formulations of naltrexoneGARBUTT, James C.The Journal of clinical psychiatry. 2006, Vol 67, pp 30-34, issn 0160-6689, 5 p., SUP14Article